Used primarily in pharmaceutical research as a key intermediate in the synthesis of targeted cancer therapies. Its structure supports the development of kinase inhibitors, particularly those involved in signal transduction pathways in tumor cells. The compound’s functional groups enable selective binding and improved pharmacokinetic properties, making it valuable in optimizing drug candidates for potency and metabolic stability. It is also employed in structure-activity relationship (SAR) studies to enhance the efficacy and selectivity of oncology drug leads.